LMTK2 Inhibits Metastasis of Colon Cancer Cells Through p38 MAPK

Cancer Science · Published 2026-08-04 · DOI 10.1111/cas.70490

Free full text

Authors (7)

Jie Lun, Jinzhao Zhang, Jianxin Xu, Liyuan Jing, Yanqing Qin, Jing Fang, Mengchao Yu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lun, J., Zhang, J., Xu, J., et al. (2026). LMTK2 Inhibits Metastasis of Colon Cancer Cells Through p38 MAPK. Cancer Science. https://doi.org/10.1111/cas.70490

Related articles

• Targeting the NR3C1 ‐ ACSL4 Axis Triggers Ferroptosis to Overcome Radioresistance in Prostate Cancer · Cancer Science · 2026 · Same journal
• New Treatment Strategy and Future Research Direction for BRAF ‐Mutated Cancer · Cancer Science · 2026 · Same journal
• Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB – IIIA Non‐Small‐Cell Lung Cancer: Phase 2 neoSCORE Trial · Cancer Science · 2026 · Same journal
• circMAN1A2 as an Isoform‐Resolved Circular RNA Hub in Cancer · Cancer Science · 2026 · Same journal
• RASD 2 Drives Renal Clear Cell Carcinoma Progression via RAF 1 (Ser338) Phosphorylation · Cancer Science · 2026 · Same journal
• Bile‐Derived Exosomal miR ‐196a/‐196b as Diagnostic Biomarkers Associated With Tumor Progression in Biliary Tract Cancer · Cancer Science · 2026 · Same journal
• Transporter‐Associated Therapeutic Efficacy of an SMVT ‐Targeted Boron Carrier in Boron Neutron Capture Therapy · Cancer Science · 2026 · Same journal
• Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer · Cancer Science · 2026 · Same journal
• Ketogenic Diet and β‐Hydroxybutyrate Suppress Bladder Cancer Growth and Enhance Anti‐ PD ‐ L1 Immunotherapy Efficacy · Cancer Science · 2026 · Same journal
• A Three‐Dimensional Culture–Drug Sensitivity Test Predicts MDM2 Inhibitor–Sensitivity in SMARCB1 / INI1 ‐Deficient Tumors · Cancer Science · 2026 · Same journal